Comparing policies across US drug markets

0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In democracies, drug policy is shaped by expectations of problems as well as by public preferences and political realities. As public preferences shift, so too will the systems of control. But systems of control have their own costs. There are the costs of maintaining the regulatory system, the costs of the black markets that emerge in response to the regulation, the costs of criminalizing behavior of otherwise law-abiding citizens, and the costs of forgone liberties. Some markets, such as heroin, are entirely prohibited. In contrast, in states that have legalized recreational marijuana in the United States, the focus is on product safety and reducing problem use and youth access, with targeted regulation and taxation. Some harmful substances are permitted under the ordinary regulations that apply to any sort of commerce (such as sugar) or with special regulation and taxes (such as alcohol). The relative social costs and benefits of systems of control are hard to assess, and these calculations are rarely performed. The challenge is in designing a system that does less harm than the harmful behavior it targets.

Cite

CITATION STYLE

APA

Hawken, A. (2017). Comparing policies across US drug markets. In Dual Markets: Comparative Approaches to Regulation (pp. 181–190). Springer International Publishing. https://doi.org/10.1007/978-3-319-65361-7_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free